Rankings
▼
Calendar
ACRS Q1 2024 Earnings — Aclaris Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
ACRS
Aclaris Therapeutics, Inc.
$435M
Q1 2024 Earnings
Healthcare
Medical - Diagnostics & Research
Income Statement
Revenue
$2M
-5.1% YoY
Gross Profit
$558,000
23.3% margin
Operating Income
-$19M
-789.4% margin
Net Income
-$17M
-706.5% margin
EPS (Diluted)
$-0.24
QoQ Revenue Growth
-86.4%
Cash Flow
Operating Cash Flow
-$21M
Free Cash Flow
-$21M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$174M
Total Liabilities
$32M
Stockholders' Equity
$142M
Cash & Equivalents
$36M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$2M
$3M
-5.1%
Gross Profit
$558,000
$659,000
-15.3%
Operating Income
-$19M
-$30M
+36.7%
Net Income
-$17M
-$28M
+39.8%
Revenue Segments
License and Service
$2M
73%
Contract research
$657,000
27%
← FY 2024
All Quarters
Q2 2024 →